Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565
Edge
RAB5A → KPNA1
Networks Including this Edge
| GSE10927_egf1520 - GSE10927 - SiGN-BN HC+Bootstrap | Human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10), on Affymetrix HG_U133_plus_2 arrays |
| GSE11582_egf1520 - GSE11582 - SiGN-BN HC+Bootstrap | Genetic Analysis of Human Traits In-Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines |
| GSE12276_egf1520 - GSE12276 - SiGN-BN HC+Bootstrap | Expression data from primary breast tumors |
| GSE12470_egf1520 - GSE12470 - SiGN-BN HC+Bootstrap | Gene expression profiles of serous ovarian cancer samples |
| GSE13996_egf1520 - GSE13996 - SiGN-BN HC+Bootstrap | Molecular profiling of classical Hodgkin’s lymphoma tissues |
| GSE15641_egf1520 - GSE15641 - SiGN-BN HC+Bootstrap | Gene signatures of progression and metastasis in renal cell cancer |
| GSE16382_egf1520 - GSE16382 - SiGN-BN HC+Bootstrap | Expression data from complex genetic sarcomas |
| GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| GSE17536_egf1520 - GSE17536 - SiGN-BN HC+Bootstrap | Metastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients (Moffitt Samples) |
| GSE20271_egf1520 - GSE20271 - SiGN-BN HC+Bootstrap | Expression data from breast cancer FNA biopsies from patients |
| GSE21050_egf1520 - GSE21050 - SiGN-BN HC+Bootstrap | Expression data from Complex genetics sarcomas (cohort 1 and 2) |
| GSE21122_egf1520 - GSE21122 - SiGN-BN HC+Bootstrap | Whole-transcript expression data for soft-tissue sarcoma tumors and control normal fat specimens |
| GSE21653_egf1520 - GSE21653 - SiGN-BN HC+Bootstrap | A gene expression signature identifies two prognostic subgroups of basal breast cancer |
| GSE22541_egf1520 - GSE22541 - SiGN-BN HC+Bootstrap | Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals |
| GSE23980_egf1520 - GSE23980 - SiGN-BN HC+Bootstrap | Expression data from human soft tissue sarcomas with complex genomics |
| GSE24124_egf1520 - GSE24124 - SiGN-BN HC+Bootstrap | Major gene partners of a favorable biomarker in ER(+) breast cancer |
| GSE26906_egf1520 - GSE26906 - SiGN-BN HC+Bootstrap | APC colon stage II |
| GSE29288_egf1520 - GSE29288 - SiGN-BN HC+Bootstrap | Comparison between cell lines from 9 different cancer tissue (NCI-60) (Agilent WG platform) |
| GSE29354_egf1520 - GSE29354 - SiGN-BN HC+Bootstrap | Mesothelioma tumor gene expression profiles |
| GSE29683_egf1520 - GSE29683 - SiGN-BN HC+Bootstrap | Coexpression of Normally Incompatible Developmental Pathways in Retinoblastoma Genesis [human tumor/cell line data] |
| GSE30929_egf1520 - GSE30929 - SiGN-BN HC+Bootstrap | Whole-transcript expression data for liposarcoma |
| GSE3167_egf1520 - GSE3167 - SiGN-BN HC+Bootstrap | Classification of carcinoma in situ lesions in human bladder cancer |
| GSE5107_egf1520 - GSE5107 - SiGN-BN HC+Bootstrap | Distinct Transcription Profiles of Primary and Secondary Glioblastomas |
| GSE6764_egf1520 - GSE6764 - SiGN-BN HC+Bootstrap | Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma |
| GSE6956_egf1520 - GSE6956 - SiGN-BN HC+Bootstrap | Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men |
| GSE9195_egf1520 - GSE9195 - SiGN-BN HC+Bootstrap | Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen |
